The 5 analysts offering 12-month price forecasts for Novavax Inc have a median target of 317.00, with a high estimate of 365.00 and a low estimate of 285.00. The median estimate represents a +48.84% increase from the last price of 212.98.
The current consensus among 5 polled investment analysts is to Buy stock in Novavax Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$3.60
Reporting Date May 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.